Neuroscience
Forbes.com offers a take on what's happening in the insomnia market:
The Next Ambien?
Matthew Herper
Forbes.com
07.21.05, 6:00 AM ET
Read the article.
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Fda: Insomnia Drug Approval
From the FDA: For Immediate Release: Nov. 23, 2011 FDA approves first insomnia drug for middle-of-the-night waking followed by difficulty returning to sleep [snippet] The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual...
- In The Weeklies: Pharmacotherapy In Older Adults
In the current issue of the British Medical Journal: Jennifer Glass, Krista L Lanctôt, Nathan Herrmann, Beth A Sproule, & Usoa E Busto. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. British Medical Journal; 2005;...
- In The Weeklies: Status Epilepticus
This week's British Medical Journal includes a clinical review of status epilepticus: Matthew Walker. Status epilepticus: An evidence based guide. British Medical Journal. 2005; 331: 673-677 (24 September). [doi:10.1136/bmj.331.7518.673] [ ......
- Business World: New Insomnia Meds, Including Takeda's Ramelteon (rozerem, Tak-375)
A brief overview to some of the anticipated insomnia medications trending from this year to next, this is from a recent Reuters report, as published on the International Herald Tribune website:New entries shake insomnia market's slumber Reuters ...
- Business World: Takeda's Ramelteon (tak-375)
A Reuters report:Takeda may extend sleeping pill's use for Alzheimer's Mon Jul 11, 2005 05:41 AM ET TOKYO, July 11 (Reuters) - Japan's biggest drug maker, Takeda Pharmaceutical Co. Ltd ... said on Monday it is on track to release a sleeping...
Neuroscience
Business World: New Insomnia Meds, Including Takeda's Ramelteon (Rozerem, TAK-375) (cont.)
Forbes.com offers a take on what's happening in the insomnia market:
The Next Ambien?
Matthew Herper
Forbes.com
07.21.05, 6:00 AM ET
Read the article.
-
Anthony H. Risser | neuroscience | neuropsychology | brain
- Fda: Insomnia Drug Approval
From the FDA: For Immediate Release: Nov. 23, 2011 FDA approves first insomnia drug for middle-of-the-night waking followed by difficulty returning to sleep [snippet] The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual...
- In The Weeklies: Pharmacotherapy In Older Adults
In the current issue of the British Medical Journal: Jennifer Glass, Krista L Lanctôt, Nathan Herrmann, Beth A Sproule, & Usoa E Busto. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. British Medical Journal; 2005;...
- In The Weeklies: Status Epilepticus
This week's British Medical Journal includes a clinical review of status epilepticus: Matthew Walker. Status epilepticus: An evidence based guide. British Medical Journal. 2005; 331: 673-677 (24 September). [doi:10.1136/bmj.331.7518.673] [ ......
- Business World: New Insomnia Meds, Including Takeda's Ramelteon (rozerem, Tak-375)
A brief overview to some of the anticipated insomnia medications trending from this year to next, this is from a recent Reuters report, as published on the International Herald Tribune website:New entries shake insomnia market's slumber Reuters ...
- Business World: Takeda's Ramelteon (tak-375)
A Reuters report:Takeda may extend sleeping pill's use for Alzheimer's Mon Jul 11, 2005 05:41 AM ET TOKYO, July 11 (Reuters) - Japan's biggest drug maker, Takeda Pharmaceutical Co. Ltd ... said on Monday it is on track to release a sleeping...